nodes	percent_of_prediction	percent_of_DWPC	metapath
Iron—Chills—Methotrexate—breast cancer	0.000196	0.000196	CcSEcCtD
Iron—Headache—Mitoxantrone—breast cancer	0.000195	0.000195	CcSEcCtD
Iron—Headache—Irinotecan—breast cancer	0.000195	0.000195	CcSEcCtD
Iron—Hypotension—Capecitabine—breast cancer	0.000195	0.000195	CcSEcCtD
Iron—Paraesthesia—Docetaxel—breast cancer	0.000194	0.000194	CcSEcCtD
Iron—Vomiting—Gemcitabine—breast cancer	0.000193	0.000193	CcSEcCtD
Iron—Bradycardia—Doxorubicin—breast cancer	0.000193	0.000193	CcSEcCtD
Iron—Dyspnoea—Docetaxel—breast cancer	0.000192	0.000192	CcSEcCtD
Iron—Somnolence—Docetaxel—breast cancer	0.000192	0.000192	CcSEcCtD
Iron—Rash—Gemcitabine—breast cancer	0.000192	0.000192	CcSEcCtD
Iron—Dermatitis—Gemcitabine—breast cancer	0.000191	0.000191	CcSEcCtD
Iron—Eye disorder—Epirubicin—breast cancer	0.000191	0.000191	CcSEcCtD
Iron—Malnutrition—Methotrexate—breast cancer	0.00019	0.00019	CcSEcCtD
Iron—Erythema—Methotrexate—breast cancer	0.00019	0.00019	CcSEcCtD
Iron—Haemoglobin—Doxorubicin—breast cancer	0.00019	0.00019	CcSEcCtD
Iron—Headache—Gemcitabine—breast cancer	0.00019	0.00019	CcSEcCtD
Iron—Musculoskeletal discomfort—Capecitabine—breast cancer	0.00019	0.00019	CcSEcCtD
Iron—Flushing—Epirubicin—breast cancer	0.00019	0.00019	CcSEcCtD
Iron—Vomiting—Fluorouracil—breast cancer	0.00019	0.00019	CcSEcCtD
Iron—Rhinitis—Doxorubicin—breast cancer	0.00019	0.00019	CcSEcCtD
Iron—Dyspepsia—Docetaxel—breast cancer	0.00019	0.00019	CcSEcCtD
Iron—Haemorrhage—Doxorubicin—breast cancer	0.000189	0.000189	CcSEcCtD
Iron—Hypoaesthesia—Doxorubicin—breast cancer	0.000188	0.000188	CcSEcCtD
Iron—Rash—Fluorouracil—breast cancer	0.000188	0.000188	CcSEcCtD
Iron—Dermatitis—Fluorouracil—breast cancer	0.000188	0.000188	CcSEcCtD
Iron—Pharyngitis—Doxorubicin—breast cancer	0.000188	0.000188	CcSEcCtD
Iron—Paraesthesia—Capecitabine—breast cancer	0.000187	0.000187	CcSEcCtD
Iron—Decreased appetite—Docetaxel—breast cancer	0.000187	0.000187	CcSEcCtD
Iron—Hypersensitivity—Paclitaxel—breast cancer	0.000187	0.000187	CcSEcCtD
Iron—Headache—Fluorouracil—breast cancer	0.000187	0.000187	CcSEcCtD
Iron—Oedema peripheral—Doxorubicin—breast cancer	0.000187	0.000187	CcSEcCtD
Iron—Dysgeusia—Methotrexate—breast cancer	0.000186	0.000186	CcSEcCtD
Iron—Gastrointestinal disorder—Docetaxel—breast cancer	0.000186	0.000186	CcSEcCtD
Iron—Dyspnoea—Capecitabine—breast cancer	0.000186	0.000186	CcSEcCtD
Iron—Fatigue—Docetaxel—breast cancer	0.000186	0.000186	CcSEcCtD
Iron—Angiopathy—Epirubicin—breast cancer	0.000186	0.000186	CcSEcCtD
Iron—Nausea—Mitoxantrone—breast cancer	0.000185	0.000185	CcSEcCtD
Iron—Nausea—Irinotecan—breast cancer	0.000185	0.000185	CcSEcCtD
Iron—Mediastinal disorder—Epirubicin—breast cancer	0.000184	0.000184	CcSEcCtD
Iron—Pain—Docetaxel—breast cancer	0.000184	0.000184	CcSEcCtD
Iron—Constipation—Docetaxel—breast cancer	0.000184	0.000184	CcSEcCtD
Iron—Back pain—Methotrexate—breast cancer	0.000184	0.000184	CcSEcCtD
Iron—Dyspepsia—Capecitabine—breast cancer	0.000184	0.000184	CcSEcCtD
Iron—Chills—Epirubicin—breast cancer	0.000184	0.000184	CcSEcCtD
Iron—Arrhythmia—Epirubicin—breast cancer	0.000183	0.000183	CcSEcCtD
Iron—Asthenia—Paclitaxel—breast cancer	0.000182	0.000182	CcSEcCtD
Iron—Decreased appetite—Capecitabine—breast cancer	0.000181	0.000181	CcSEcCtD
Iron—Nausea—Gemcitabine—breast cancer	0.00018	0.00018	CcSEcCtD
Iron—Gastrointestinal disorder—Capecitabine—breast cancer	0.00018	0.00018	CcSEcCtD
Iron—Fatigue—Capecitabine—breast cancer	0.00018	0.00018	CcSEcCtD
Iron—Pruritus—Paclitaxel—breast cancer	0.00018	0.00018	CcSEcCtD
Iron—Pain—Capecitabine—breast cancer	0.000178	0.000178	CcSEcCtD
Iron—Constipation—Capecitabine—breast cancer	0.000178	0.000178	CcSEcCtD
Iron—Malnutrition—Epirubicin—breast cancer	0.000178	0.000178	CcSEcCtD
Iron—Erythema—Epirubicin—breast cancer	0.000178	0.000178	CcSEcCtD
Iron—Feeling abnormal—Docetaxel—breast cancer	0.000178	0.000178	CcSEcCtD
Iron—Nausea—Fluorouracil—breast cancer	0.000177	0.000177	CcSEcCtD
Iron—Eye disorder—Doxorubicin—breast cancer	0.000177	0.000177	CcSEcCtD
Iron—Ill-defined disorder—Methotrexate—breast cancer	0.000177	0.000177	CcSEcCtD
Iron—Gastrointestinal pain—Docetaxel—breast cancer	0.000176	0.000176	CcSEcCtD
Iron—Anaemia—Methotrexate—breast cancer	0.000176	0.000176	CcSEcCtD
Iron—Flushing—Doxorubicin—breast cancer	0.000176	0.000176	CcSEcCtD
Iron—Flatulence—Epirubicin—breast cancer	0.000176	0.000176	CcSEcCtD
Iron—Tension—Epirubicin—breast cancer	0.000175	0.000175	CcSEcCtD
Iron—Dysgeusia—Epirubicin—breast cancer	0.000174	0.000174	CcSEcCtD
Iron—Diarrhoea—Paclitaxel—breast cancer	0.000174	0.000174	CcSEcCtD
Iron—Nervousness—Epirubicin—breast cancer	0.000173	0.000173	CcSEcCtD
Iron—Back pain—Epirubicin—breast cancer	0.000172	0.000172	CcSEcCtD
Iron—Feeling abnormal—Capecitabine—breast cancer	0.000172	0.000172	CcSEcCtD
Iron—Angiopathy—Doxorubicin—breast cancer	0.000172	0.000172	CcSEcCtD
Iron—Malaise—Methotrexate—breast cancer	0.000172	0.000172	CcSEcCtD
Iron—Muscle spasms—Epirubicin—breast cancer	0.000171	0.000171	CcSEcCtD
Iron—Gastrointestinal pain—Capecitabine—breast cancer	0.000171	0.000171	CcSEcCtD
Iron—Mediastinal disorder—Doxorubicin—breast cancer	0.000171	0.000171	CcSEcCtD
Iron—Abdominal pain—Docetaxel—breast cancer	0.00017	0.00017	CcSEcCtD
Iron—Body temperature increased—Docetaxel—breast cancer	0.00017	0.00017	CcSEcCtD
Iron—Chills—Doxorubicin—breast cancer	0.00017	0.00017	CcSEcCtD
Iron—Arrhythmia—Doxorubicin—breast cancer	0.000169	0.000169	CcSEcCtD
Iron—Dizziness—Paclitaxel—breast cancer	0.000168	0.000168	CcSEcCtD
Iron—Cough—Methotrexate—breast cancer	0.000166	0.000166	CcSEcCtD
Iron—Urticaria—Capecitabine—breast cancer	0.000166	0.000166	CcSEcCtD
Iron—Ill-defined disorder—Epirubicin—breast cancer	0.000165	0.000165	CcSEcCtD
Iron—Abdominal pain—Capecitabine—breast cancer	0.000165	0.000165	CcSEcCtD
Iron—Body temperature increased—Capecitabine—breast cancer	0.000165	0.000165	CcSEcCtD
Iron—Convulsion—Methotrexate—breast cancer	0.000165	0.000165	CcSEcCtD
Iron—Malnutrition—Doxorubicin—breast cancer	0.000165	0.000165	CcSEcCtD
Iron—Erythema—Doxorubicin—breast cancer	0.000165	0.000165	CcSEcCtD
Iron—Anaemia—Epirubicin—breast cancer	0.000165	0.000165	CcSEcCtD
Iron—Agitation—Epirubicin—breast cancer	0.000164	0.000164	CcSEcCtD
Iron—Flatulence—Doxorubicin—breast cancer	0.000162	0.000162	CcSEcCtD
Iron—Myalgia—Methotrexate—breast cancer	0.000162	0.000162	CcSEcCtD
Iron—Arthralgia—Methotrexate—breast cancer	0.000162	0.000162	CcSEcCtD
Iron—Chest pain—Methotrexate—breast cancer	0.000162	0.000162	CcSEcCtD
Iron—Tension—Doxorubicin—breast cancer	0.000162	0.000162	CcSEcCtD
Iron—Vomiting—Paclitaxel—breast cancer	0.000162	0.000162	CcSEcCtD
Iron—Dysgeusia—Doxorubicin—breast cancer	0.000161	0.000161	CcSEcCtD
Iron—Malaise—Epirubicin—breast cancer	0.000161	0.000161	CcSEcCtD
Iron—Rash—Paclitaxel—breast cancer	0.00016	0.00016	CcSEcCtD
Iron—Dermatitis—Paclitaxel—breast cancer	0.00016	0.00016	CcSEcCtD
Iron—Discomfort—Methotrexate—breast cancer	0.00016	0.00016	CcSEcCtD
Iron—Nervousness—Doxorubicin—breast cancer	0.00016	0.00016	CcSEcCtD
Iron—Syncope—Epirubicin—breast cancer	0.00016	0.00016	CcSEcCtD
Iron—Back pain—Doxorubicin—breast cancer	0.000159	0.000159	CcSEcCtD
Iron—Headache—Paclitaxel—breast cancer	0.000159	0.000159	CcSEcCtD
Iron—Hypersensitivity—Docetaxel—breast cancer	0.000159	0.000159	CcSEcCtD
Iron—Muscle spasms—Doxorubicin—breast cancer	0.000158	0.000158	CcSEcCtD
Iron—Confusional state—Methotrexate—breast cancer	0.000157	0.000157	CcSEcCtD
Iron—Loss of consciousness—Epirubicin—breast cancer	0.000157	0.000157	CcSEcCtD
Iron—Cough—Epirubicin—breast cancer	0.000155	0.000155	CcSEcCtD
Iron—Anaphylactic shock—Methotrexate—breast cancer	0.000155	0.000155	CcSEcCtD
Iron—Asthenia—Docetaxel—breast cancer	0.000155	0.000155	CcSEcCtD
Iron—Convulsion—Epirubicin—breast cancer	0.000154	0.000154	CcSEcCtD
Iron—Infection—Methotrexate—breast cancer	0.000154	0.000154	CcSEcCtD
Iron—Hypertension—Epirubicin—breast cancer	0.000154	0.000154	CcSEcCtD
Iron—Hypersensitivity—Capecitabine—breast cancer	0.000154	0.000154	CcSEcCtD
Iron—Ill-defined disorder—Doxorubicin—breast cancer	0.000153	0.000153	CcSEcCtD
Iron—Pruritus—Docetaxel—breast cancer	0.000153	0.000153	CcSEcCtD
Iron—Nervous system disorder—Methotrexate—breast cancer	0.000152	0.000152	CcSEcCtD
Iron—Anaemia—Doxorubicin—breast cancer	0.000152	0.000152	CcSEcCtD
Iron—Arthralgia—Epirubicin—breast cancer	0.000152	0.000152	CcSEcCtD
Iron—Myalgia—Epirubicin—breast cancer	0.000152	0.000152	CcSEcCtD
Iron—Chest pain—Epirubicin—breast cancer	0.000152	0.000152	CcSEcCtD
Iron—Agitation—Doxorubicin—breast cancer	0.000151	0.000151	CcSEcCtD
Iron—Nausea—Paclitaxel—breast cancer	0.000151	0.000151	CcSEcCtD
Iron—Hyperhidrosis—Methotrexate—breast cancer	0.00015	0.00015	CcSEcCtD
Iron—Discomfort—Epirubicin—breast cancer	0.00015	0.00015	CcSEcCtD
Iron—Asthenia—Capecitabine—breast cancer	0.00015	0.00015	CcSEcCtD
Iron—Malaise—Doxorubicin—breast cancer	0.000149	0.000149	CcSEcCtD
Iron—Dry mouth—Epirubicin—breast cancer	0.000148	0.000148	CcSEcCtD
Iron—Anorexia—Methotrexate—breast cancer	0.000148	0.000148	CcSEcCtD
Iron—Syncope—Doxorubicin—breast cancer	0.000148	0.000148	CcSEcCtD
Iron—Pruritus—Capecitabine—breast cancer	0.000148	0.000148	CcSEcCtD
Iron—Diarrhoea—Docetaxel—breast cancer	0.000147	0.000147	CcSEcCtD
Iron—Confusional state—Epirubicin—breast cancer	0.000147	0.000147	CcSEcCtD
Iron—Anaphylactic shock—Epirubicin—breast cancer	0.000145	0.000145	CcSEcCtD
Iron—Oedema—Epirubicin—breast cancer	0.000145	0.000145	CcSEcCtD
Iron—Hypotension—Methotrexate—breast cancer	0.000145	0.000145	CcSEcCtD
Iron—Loss of consciousness—Doxorubicin—breast cancer	0.000145	0.000145	CcSEcCtD
Iron—Infection—Epirubicin—breast cancer	0.000144	0.000144	CcSEcCtD
Iron—Cough—Doxorubicin—breast cancer	0.000144	0.000144	CcSEcCtD
Iron—Shock—Epirubicin—breast cancer	0.000143	0.000143	CcSEcCtD
Iron—Convulsion—Doxorubicin—breast cancer	0.000143	0.000143	CcSEcCtD
Iron—Diarrhoea—Capecitabine—breast cancer	0.000143	0.000143	CcSEcCtD
Iron—Nervous system disorder—Epirubicin—breast cancer	0.000143	0.000143	CcSEcCtD
Iron—Dizziness—Docetaxel—breast cancer	0.000143	0.000143	CcSEcCtD
Iron—Hypertension—Doxorubicin—breast cancer	0.000142	0.000142	CcSEcCtD
Iron—Tachycardia—Epirubicin—breast cancer	0.000142	0.000142	CcSEcCtD
Iron—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000142	0.000142	CcSEcCtD
Iron—Hyperhidrosis—Epirubicin—breast cancer	0.000141	0.000141	CcSEcCtD
Iron—Myalgia—Doxorubicin—breast cancer	0.00014	0.00014	CcSEcCtD
Iron—Arthralgia—Doxorubicin—breast cancer	0.00014	0.00014	CcSEcCtD
Iron—Chest pain—Doxorubicin—breast cancer	0.00014	0.00014	CcSEcCtD
Iron—Paraesthesia—Methotrexate—breast cancer	0.00014	0.00014	CcSEcCtD
Iron—Discomfort—Doxorubicin—breast cancer	0.000139	0.000139	CcSEcCtD
Iron—Anorexia—Epirubicin—breast cancer	0.000139	0.000139	CcSEcCtD
Iron—Dyspnoea—Methotrexate—breast cancer	0.000139	0.000139	CcSEcCtD
Iron—Somnolence—Methotrexate—breast cancer	0.000138	0.000138	CcSEcCtD
Iron—Dizziness—Capecitabine—breast cancer	0.000138	0.000138	CcSEcCtD
Iron—Dry mouth—Doxorubicin—breast cancer	0.000137	0.000137	CcSEcCtD
Iron—Vomiting—Docetaxel—breast cancer	0.000137	0.000137	CcSEcCtD
Iron—Dyspepsia—Methotrexate—breast cancer	0.000137	0.000137	CcSEcCtD
Iron—Rash—Docetaxel—breast cancer	0.000136	0.000136	CcSEcCtD
Iron—Hypotension—Epirubicin—breast cancer	0.000136	0.000136	CcSEcCtD
Iron—Dermatitis—Docetaxel—breast cancer	0.000136	0.000136	CcSEcCtD
Iron—Confusional state—Doxorubicin—breast cancer	0.000136	0.000136	CcSEcCtD
Iron—Decreased appetite—Methotrexate—breast cancer	0.000135	0.000135	CcSEcCtD
Iron—Headache—Docetaxel—breast cancer	0.000135	0.000135	CcSEcCtD
Iron—Oedema—Doxorubicin—breast cancer	0.000135	0.000135	CcSEcCtD
Iron—Anaphylactic shock—Doxorubicin—breast cancer	0.000135	0.000135	CcSEcCtD
Iron—Gastrointestinal disorder—Methotrexate—breast cancer	0.000134	0.000134	CcSEcCtD
Iron—Fatigue—Methotrexate—breast cancer	0.000134	0.000134	CcSEcCtD
Iron—Infection—Doxorubicin—breast cancer	0.000134	0.000134	CcSEcCtD
Iron—Pain—Methotrexate—breast cancer	0.000133	0.000133	CcSEcCtD
Iron—Vomiting—Capecitabine—breast cancer	0.000133	0.000133	CcSEcCtD
Iron—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000132	0.000132	CcSEcCtD
Iron—Shock—Doxorubicin—breast cancer	0.000132	0.000132	CcSEcCtD
Iron—Nervous system disorder—Doxorubicin—breast cancer	0.000132	0.000132	CcSEcCtD
Iron—Rash—Capecitabine—breast cancer	0.000132	0.000132	CcSEcCtD
Iron—Dermatitis—Capecitabine—breast cancer	0.000131	0.000131	CcSEcCtD
Iron—Tachycardia—Doxorubicin—breast cancer	0.000131	0.000131	CcSEcCtD
Iron—Headache—Capecitabine—breast cancer	0.000131	0.000131	CcSEcCtD
Iron—Paraesthesia—Epirubicin—breast cancer	0.000131	0.000131	CcSEcCtD
Iron—Hyperhidrosis—Doxorubicin—breast cancer	0.00013	0.00013	CcSEcCtD
Iron—Dyspnoea—Epirubicin—breast cancer	0.00013	0.00013	CcSEcCtD
Iron—Somnolence—Epirubicin—breast cancer	0.000129	0.000129	CcSEcCtD
Iron—Anorexia—Doxorubicin—breast cancer	0.000128	0.000128	CcSEcCtD
Iron—Nausea—Docetaxel—breast cancer	0.000128	0.000128	CcSEcCtD
Iron—Feeling abnormal—Methotrexate—breast cancer	0.000128	0.000128	CcSEcCtD
Iron—Dyspepsia—Epirubicin—breast cancer	0.000128	0.000128	CcSEcCtD
Iron—Gastrointestinal pain—Methotrexate—breast cancer	0.000127	0.000127	CcSEcCtD
Iron—Decreased appetite—Epirubicin—breast cancer	0.000126	0.000126	CcSEcCtD
Iron—Hypotension—Doxorubicin—breast cancer	0.000126	0.000126	CcSEcCtD
Iron—Gastrointestinal disorder—Epirubicin—breast cancer	0.000126	0.000126	CcSEcCtD
Iron—Fatigue—Epirubicin—breast cancer	0.000125	0.000125	CcSEcCtD
Iron—Pain—Epirubicin—breast cancer	0.000124	0.000124	CcSEcCtD
Iron—Constipation—Epirubicin—breast cancer	0.000124	0.000124	CcSEcCtD
Iron—Nausea—Capecitabine—breast cancer	0.000124	0.000124	CcSEcCtD
Iron—Urticaria—Methotrexate—breast cancer	0.000123	0.000123	CcSEcCtD
Iron—Body temperature increased—Methotrexate—breast cancer	0.000123	0.000123	CcSEcCtD
Iron—Abdominal pain—Methotrexate—breast cancer	0.000123	0.000123	CcSEcCtD
Iron—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000123	0.000123	CcSEcCtD
Iron—Paraesthesia—Doxorubicin—breast cancer	0.000121	0.000121	CcSEcCtD
Iron—Dyspnoea—Doxorubicin—breast cancer	0.00012	0.00012	CcSEcCtD
Iron—Feeling abnormal—Epirubicin—breast cancer	0.00012	0.00012	CcSEcCtD
Iron—Somnolence—Doxorubicin—breast cancer	0.00012	0.00012	CcSEcCtD
Iron—Gastrointestinal pain—Epirubicin—breast cancer	0.000119	0.000119	CcSEcCtD
Iron—Dyspepsia—Doxorubicin—breast cancer	0.000118	0.000118	CcSEcCtD
Iron—Decreased appetite—Doxorubicin—breast cancer	0.000117	0.000117	CcSEcCtD
Iron—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000116	0.000116	CcSEcCtD
Iron—Fatigue—Doxorubicin—breast cancer	0.000116	0.000116	CcSEcCtD
Iron—Urticaria—Epirubicin—breast cancer	0.000116	0.000116	CcSEcCtD
Iron—Pain—Doxorubicin—breast cancer	0.000115	0.000115	CcSEcCtD
Iron—Constipation—Doxorubicin—breast cancer	0.000115	0.000115	CcSEcCtD
Iron—Body temperature increased—Epirubicin—breast cancer	0.000115	0.000115	CcSEcCtD
Iron—Abdominal pain—Epirubicin—breast cancer	0.000115	0.000115	CcSEcCtD
Iron—Hypersensitivity—Methotrexate—breast cancer	0.000114	0.000114	CcSEcCtD
Iron—Asthenia—Methotrexate—breast cancer	0.000111	0.000111	CcSEcCtD
Iron—Feeling abnormal—Doxorubicin—breast cancer	0.000111	0.000111	CcSEcCtD
Iron—Gastrointestinal pain—Doxorubicin—breast cancer	0.00011	0.00011	CcSEcCtD
Iron—Pruritus—Methotrexate—breast cancer	0.00011	0.00011	CcSEcCtD
Iron—Hypersensitivity—Epirubicin—breast cancer	0.000107	0.000107	CcSEcCtD
Iron—Urticaria—Doxorubicin—breast cancer	0.000107	0.000107	CcSEcCtD
Iron—Body temperature increased—Doxorubicin—breast cancer	0.000106	0.000106	CcSEcCtD
Iron—Abdominal pain—Doxorubicin—breast cancer	0.000106	0.000106	CcSEcCtD
Iron—Diarrhoea—Methotrexate—breast cancer	0.000106	0.000106	CcSEcCtD
Iron—Asthenia—Epirubicin—breast cancer	0.000104	0.000104	CcSEcCtD
Iron—Pruritus—Epirubicin—breast cancer	0.000103	0.000103	CcSEcCtD
Iron—Dizziness—Methotrexate—breast cancer	0.000103	0.000103	CcSEcCtD
Iron—Diarrhoea—Epirubicin—breast cancer	9.95e-05	9.95e-05	CcSEcCtD
Iron—Hypersensitivity—Doxorubicin—breast cancer	9.91e-05	9.91e-05	CcSEcCtD
Iron—Vomiting—Methotrexate—breast cancer	9.88e-05	9.88e-05	CcSEcCtD
Iron—Rash—Methotrexate—breast cancer	9.8e-05	9.8e-05	CcSEcCtD
Iron—Dermatitis—Methotrexate—breast cancer	9.79e-05	9.79e-05	CcSEcCtD
Iron—Headache—Methotrexate—breast cancer	9.73e-05	9.73e-05	CcSEcCtD
Iron—Asthenia—Doxorubicin—breast cancer	9.65e-05	9.65e-05	CcSEcCtD
Iron—Dizziness—Epirubicin—breast cancer	9.62e-05	9.62e-05	CcSEcCtD
Iron—Pruritus—Doxorubicin—breast cancer	9.52e-05	9.52e-05	CcSEcCtD
Iron—Vomiting—Epirubicin—breast cancer	9.24e-05	9.24e-05	CcSEcCtD
Iron—Nausea—Methotrexate—breast cancer	9.23e-05	9.23e-05	CcSEcCtD
Iron—Diarrhoea—Doxorubicin—breast cancer	9.21e-05	9.21e-05	CcSEcCtD
Iron—Rash—Epirubicin—breast cancer	9.17e-05	9.17e-05	CcSEcCtD
Iron—Dermatitis—Epirubicin—breast cancer	9.16e-05	9.16e-05	CcSEcCtD
Iron—Headache—Epirubicin—breast cancer	9.11e-05	9.11e-05	CcSEcCtD
Iron—Dizziness—Doxorubicin—breast cancer	8.9e-05	8.9e-05	CcSEcCtD
Iron—Nausea—Epirubicin—breast cancer	8.64e-05	8.64e-05	CcSEcCtD
Iron—Vomiting—Doxorubicin—breast cancer	8.55e-05	8.55e-05	CcSEcCtD
Iron—Rash—Doxorubicin—breast cancer	8.48e-05	8.48e-05	CcSEcCtD
Iron—Dermatitis—Doxorubicin—breast cancer	8.47e-05	8.47e-05	CcSEcCtD
Iron—Headache—Doxorubicin—breast cancer	8.43e-05	8.43e-05	CcSEcCtD
Iron—Nausea—Doxorubicin—breast cancer	7.99e-05	7.99e-05	CcSEcCtD
